Mary Uhlenhopp

406 total citations
10 papers, 268 citations indexed

About

Mary Uhlenhopp is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Mary Uhlenhopp has authored 10 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Otorhinolaryngology. Recurrent topics in Mary Uhlenhopp's work include Cancer Treatment and Pharmacology (4 papers), Neutropenia and Cancer Infections (2 papers) and Oral health in cancer treatment (2 papers). Mary Uhlenhopp is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Neutropenia and Cancer Infections (2 papers) and Oral health in cancer treatment (2 papers). Mary Uhlenhopp collaborates with scholars based in United States, Switzerland and United Kingdom. Mary Uhlenhopp's co-authors include Jan Geißler, Bettina Ryll, Larry Norton, Antonella Surbone, George Raptis, Clifford A. Hudis, Mary Ellen Moynahan, D. Fennelly, John Crown and Barry Quinn and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Cancer Nursing.

In The Last Decade

Mary Uhlenhopp

10 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Uhlenhopp United States 7 129 79 47 46 29 10 268
Monika Rucińska Poland 11 116 0.9× 52 0.7× 94 2.0× 24 0.5× 20 0.7× 55 333
J Haberland Germany 11 156 1.2× 35 0.4× 60 1.3× 46 1.0× 11 0.4× 20 298
Antoinette Percy‐Laurry United States 6 189 1.5× 45 0.6× 85 1.8× 38 0.8× 9 0.3× 10 332
Rori Salvaggio United States 7 304 2.4× 95 1.2× 76 1.6× 28 0.6× 10 0.3× 13 387
P. Hopwood United Kingdom 8 186 1.4× 31 0.4× 174 3.7× 38 0.8× 27 0.9× 29 390
Lisa M. Moy United States 11 158 1.2× 55 0.7× 84 1.8× 16 0.3× 14 0.5× 18 329
S. Zonato Italy 11 181 1.4× 37 0.5× 128 2.7× 10 0.2× 39 1.3× 21 375
Vida Almario Passero United States 7 78 0.6× 27 0.3× 32 0.7× 15 0.3× 36 1.2× 24 228
Akina Natori United States 9 133 1.0× 40 0.5× 70 1.5× 16 0.3× 6 0.2× 30 257
Oliver Higuera Spain 13 305 2.4× 61 0.8× 135 2.9× 50 1.1× 7 0.2× 40 480

Countries citing papers authored by Mary Uhlenhopp

Since Specialization
Citations

This map shows the geographic impact of Mary Uhlenhopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Uhlenhopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Uhlenhopp more than expected).

Fields of papers citing papers by Mary Uhlenhopp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Uhlenhopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Uhlenhopp. The network helps show where Mary Uhlenhopp may publish in the future.

Co-authorship network of co-authors of Mary Uhlenhopp

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Uhlenhopp. A scholar is included among the top collaborators of Mary Uhlenhopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Uhlenhopp. Mary Uhlenhopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Geißler, Jan, et al.. (2017). Improving Patient Involvement in Medicines Research and Development: A Practical Roadmap. Therapeutic Innovation & Regulatory Science. 51(5). 612–619. 73 indexed citations
2.
Stone, Rebecca H., Carin Potting, Simon Clare, et al.. (2007). Management of oral mucositis at European transplantation centres. European Journal of Oncology Nursing. 11. S3–S9. 9 indexed citations
3.
Quinn, Barry, Rebecca H. Stone, Mary Uhlenhopp, Shaun R. McCann, & Nicole Blijlevens. (2007). Ensuring accurate oral mucositis assessment in the European Group for Blood and Marrow Transplantation Prospective Oral Mucositis Audit. European Journal of Oncology Nursing. 11. S10–S18. 30 indexed citations
4.
Foubert, Jan, et al.. (2004). Knowledge of haematological toxicities amongst European nurses—a learning needs assessment. European Journal of Oncology Nursing. 9(3). 239–247. 7 indexed citations
5.
Uhlenhopp, Mary, Monica Fliedner, Peter W. G. Morris, & Ton van Boxtel. (1999). A global perspective on nurses' Internet access and information utilization.. PubMed. 25(10 Suppl). 27–32. 5 indexed citations
6.
Hudis, Clifford A., Andrew D. Seidman, José Baselga, et al.. (1999). Sequential Dose-Dense Doxorubicin, Paclitaxel, and Cyclophosphamide for Resectable High-Risk Breast Cancer: Feasibility and Efficacy. Journal of Clinical Oncology. 17(1). 93–93. 86 indexed citations
7.
Hudis, Clifford A., Frankie A. Holmes, Andrew D. Seidman, et al.. (1997). Phase II study of semisynthetic paclitaxel in metastatic breast cancer. European Journal of Cancer. 33(13). 2198–2202. 5 indexed citations
8.
Hudis, Clifford A., A. D. Seidman, George Raptis, et al.. (1996). Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experience.. PubMed. 23(1 Suppl 1). 58–64. 26 indexed citations
9.
Hesketh, Paul J., Thomas Beck, Mary Uhlenhopp, et al.. (1995). Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen.. Journal of Clinical Oncology. 13(8). 2117–2122. 24 indexed citations
10.
Uhlenhopp, Mary. (1992). An overview of the relationship between alkylating agents and therapy-related acute nonlymphocytic leukemia. Cancer Nursing. 15(1). 9???17–9???17. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monika Rucińska Breakdown of academic impact, for papers by J Haberland Breakdown of academic impact, for papers by Antoinette Percy‐Laurry Breakdown of academic impact, for papers by Rori Salvaggio Breakdown of academic impact, for papers by P. Hopwood Breakdown of academic impact, for papers by Lisa M. Moy Breakdown of academic impact, for papers by S. Zonato Breakdown of academic impact, for papers by Vida Almario Passero Breakdown of academic impact, for papers by Akina Natori Breakdown of academic impact, for papers by Oliver Higuera
Rankless by CCL
2026